Abstract
HUMAN stromelysin-3, a new member of the matrix metalloproteinase family, is expressed in tissues undergoing the active remodelling associated with embryonic development, wound healing and tumour invasion1–3. But like all other members of the matrix metalloproteinase gene family, stromelysin-3 is synthesized as an inactive precursor that must be processed to its mature form in order to express enzymic activity4,5. Here we identify stromelysin-3 as the first matrix metalloproteinase to be discovered that can be processed directly to its enzymically active form by an obligate intracellular proteolytic event that occurs within the constitutive secretory pathway. Intracellular activation is regulated by an unusual 10-amino-acid insert sandwiched between the pro-and catalytic-domains of stromelysin-3, which is encrypted with an Arg-X-Arg-X-Lys-Arg recognition motif for the Golgi-associated proteinase, furin, a mammalian homologue of the yeast Kex2 pher-omone convertase6,7. A furin–stromelysin-3 processing axis not only differentiates the regulation of this enzyme from all previously characterized matrix metalloproteinases, but also identifies pro-protein convertases as potential targets for therapeutic intervention in matrix-destructive disease states.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Basset, P. et al. Nature 348, 699–704 (1990).
Lefebvre, O. et al. J. Cell Biol. 119, 997–1002 (1992).
Wolf, C. et al. Proc. natn. Acad. Sci., U.S.A. 90, 1843–1847 (1993).
Matrisian, L. M. BioEssays 14, 455–463 (1992).
Birkedal-Hansen, H. et al. Crit. Rev. Oral Biol. Med. 4, 197–250 (1993).
Steiner, D. F., Smeekens, S. P., Ohagi, S. & Chan, S. J. J. biol. chem. 267, 23435–23438 (1992).
Seidah, N. G., Day, R. & Chretien, M. Biochem. Soc. Trans. 21, 685–691 (1993).
Pei, D. Q., Majmudar, G. & Weiss, S. J. J. biol. Chem. 269, 25849–25855 (1994).
Davies, B., Brown, P. Q., East, N., Crimmin, M. J. & Balkwill, E. R. Cancer Res. 53, 2087–2091 (1993).
Watanabe, T. et al. J. biol. Chem. 267, 8270–8274 (1991).
Watanabe, T., Murakami, K. & Nakayama, K. FEBS Lett. 320, 215–218 (1993).
Rehemtulla, A. & Kaufman, R. J. Blood 79, 2349–2355 (1992).
Liu, Y.-C. et al. Proc. natn. Acad. Sci. U.S.A. 90, 8957–8961 (1993).
Wasley, C. L., Rehemtulla, A. & Kaufman, R. J. J. biol. Chem. 268, 8458–8465 (1993).
Tsuneoka, M. et al. J. biol. Chem. 268, 26461–26465 (1993).
Molloy, S. S., Thomas, K. J., Van Slyke, K., Stenberg, P. E. & Thomas, G. EMBO J. 13, 18–33 (1994).
Vidricaire, J., Denault, J.-B. & Leduc, R. Biochem. biophys. Res. Commun. 195, 1011–1018 (1993).
Patterton, D., Hayes, W. P. & Shi, Y. B. Devl Biol. 167, 252–262 (1995).
Sato, H. et al. Nature 370, 61–65 (1994).
Cao, J., Sato, H., Takino, T. & Seiki, M. J. biol. Chem. 270, 801–805 (1995).
Hallenberger, S. et al. Nature 360, 358–361 (1992).
Decroly, E. et al. J. biol. Chem. 269, 12240–12247 (1994).
Ausubel, F. M. et al. (eds) Curr. Prot. molec. Biol. (Wiley, New York, 1994).
Birken, S., Fetherston, J., Canfield, R. & Boime, R. J. biol. Chem. 256, 1816–1823 (1981).
Desrochers, P. E., Mookhtiar, K., Van Wart, H., Hasty, K. A. & Weiss, S. J. J. biol. Chem. 267, 5005–5012 (1992).
Bravo, D. A., Gleason, J. B., Sanchez, R. I., Roth, R. A. & Fuller, R. S. J. biol. Chem. 269, 25830–25837 (1994).
Anderson, E. A., Thomas, L., Hayflick, J. S. & Thomas, G. J. biol. Chem. 268, 24887–24891 (1993).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Pei, D., Weiss, S. Furin-dependent intracellular activation of the human stromelysin-3 zymogen. Nature 375, 244–247 (1995). https://doi.org/10.1038/375244a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/375244a0
This article is cited by
-
The roles of intracellular proteolysis in cardiac ischemia–reperfusion injury
Basic Research in Cardiology (2023)
-
De novo disruptive heterozygous MMP21 variants are potential predisposing genetic risk factors in Chinese Han heterotaxy children
Human Genomics (2022)
-
Matrix metalloproteinase 11 (MMP11) in macrophages promotes the migration of HER2-positive breast cancer cells and monocyte recruitment through CCL2–CCR2 signaling
Laboratory Investigation (2022)
-
MMPs in learning and memory and neuropsychiatric disorders
Cellular and Molecular Life Sciences (2019)
-
Laminin and Matrix metalloproteinase 11 regulate Fibronectin levels in the zebrafish myotendinous junction
Skeletal Muscle (2016)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.
